Skip to main content
. 2020 Mar 19;45(1):165–174. doi: 10.1002/jpen.1826

Table 1.

Demographics of MD Patients and Controls

Demographics MD patients (n = 37) Controls (n = 37) P‐value
Age, y (mean ± SD) 42 ± 13 42 ± 12 .84
Female (n/%) 22 (59%) 22 (59%)
BMI, kg/m b , (median: IQR) 21.9: 19.9–24.5 23.0: 21.3–25.0 .54
BMI categories (n/%)
<18.5, kg/m b 2 (5%) 0 (0%)
<20, kg/m 2 9 (24%) 4 (11%)
20–25, kg/m 2 20 (54%) 23 (62%)
25–30, kg/m 2 6 (16%) 10 (27%)
>30, kg/m 2 2 (5%) 0 (0%)
Weight, kg (mean ± SD) 66.6 ± 12.3 72.2 ± 8.9 .04
Weight loss a (n/%) 4 (11%) 2 (5%) .39
Height, cm (mean ± SD) 170.8 ± 1.0 176.4 ± 0.9 .01
Waist circumference, cm, (mean ± SD) 84.3 ± 11.5 81.8 ± 8.0 .30
High waist circumference b (n/%) 14 (38%) 12 (32%) .46
Diet (n/%) 25 (68%) 2 (5%) <.001
Gastrointestinal problems (n/%) 28 (76%) 5 (13.5%) <.001
Dysphagia (n/%) 18 (49%) 0 (0%) <.001

P‐values ≤.02 (in bold) were considered significant.

BMI, body mass index; IQR, interquartile range; MD, mitochondrial disease.

a

Weight loss according to Global Leadership Initiative on Malnutrition (GLIM) criteria: >5% within past 6 months or >10% beyond 6 months. 29

b

High waist circumference >94 cm (women) and >80 cm (men) according to World Health Organization (WHO) 2008. 43